Spinal-Tap 发表于 2025-3-25 04:13:26
Bumetanide,centration reported after a 1 mg dose is 0.03 μg/ml. The drug is largely excreted in urine with some 10-15% in faeces. Most excreted drug is unchanged with small amounts of alcohol hydroxylation products present. The half-life in plasma is about 1-1.5 hours.START 发表于 2025-3-25 09:55:39
http://reply.papertrans.cn/29/2832/283184/283184_22.pngminaret 发表于 2025-3-25 15:11:26
http://reply.papertrans.cn/29/2832/283184/283184_23.pngLacunar-Stroke 发表于 2025-3-25 19:14:22
http://reply.papertrans.cn/29/2832/283184/283184_24.png返老还童 发表于 2025-3-25 21:04:25
Acecainide (N-Acetylprocainamide),logical activity, a longer duration of action, and produces less frequent cardiac complications and hypersensitivity reactions than procainamide. The acetylation of procainamide is subject to genetic polymorphism with 30-40% being converted in fast acetylators. Up to 85% of a dose of acecainide is e担心 发表于 2025-3-26 03:27:33
http://reply.papertrans.cn/29/2832/283184/283184_26.pnglipids 发表于 2025-3-26 07:43:31
Amikacin,Excretion in urine by glomerular filtration is largely of unchanged compound with a plasma half-life of 2 to 3 hours. Ototoxicity and nephrotoxicity are minimized by avoiding peak plasma concentrations measured one hour after administration of > 30 μg/ml or trough concentrations measured before the无底 发表于 2025-3-26 09:33:54
Amitriptyline,Amitriptyline is demethylated to nortriptyline and then by several other routes to metabolites excreted in urine. Genetic differences result in considerable inter-individual variation in metabolism, plasma half-life varying from 8 to 51 hours. The therapeutic range in plasma for treatment of endogenoverrule 发表于 2025-3-26 12:44:00
Boldenone,and produce behavioural changes of a masculinizing type in geldings and mares. Reproductive efficiency is impaired in both sexes. Metabolites appearing in urine in horses are 17α-hydroxy-epimers as glucuronic acid conjugates and unchanged drug with 17β-hydroxy compounds as sulphate conjugates.Cursory 发表于 2025-3-26 20:32:56
Bumetanide, loop of Henle in the renal tubule. Use is in the treatment of pulmonary oedema in patients with heart or renal failure. The peak effect is within 30 minutes of intravenous or 1 hour of oral administration and diuresis complete within 6 hours. Oral absorption is rapid and complete. The mean peak con